Chione Ltd, 10% Owner at Karyopharm Therapeutics Inc. (KPTI), sold 228,052 shares at $18.52 ($4.4M) on 2018-08-27, disclosed to the SEC on 2018-08-29.
Open-market sale of $4.4M KPTI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.52 | 14,026 | $260K | 5.9% |
| 2 | $18.52 | 14,026 | $260K | 5.9% |
| 3 | $19.59 | 200,000 | $3.9M | 88.3% |
| Total | $19.46 avg | 228,052 | $4.4M | 100% |
| Filing → |
| KPTI | SELL | 2016-06-08 | $370K | — | Filing → |
| KPTI | SELL | 2016-05-23 | $802K | — | Filing → |